{"pageContent": "Objectives: To describe the clinical characteristics, diagnostic features, prognosis, and outcome of patients with prostate cancer and disseminated intravascular coagulation with excessive fibrinolysis (DIC XFL).", "metaData": {"source": "Adjuvant and neoadjuvant therapies in high risk localized prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/17310835/"}}